Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-43295
J Biol Chem. July 22, 2011; 286 (29): 25903-21.

Skeletal muscle differentiation and fusion are regulated by the BAR-containing Rho-GTPase-activating protein (Rho-GAP), GRAF1.

Doherty JT , Lenhart KC , Cameron MV , Mack CP , Conlon FL , Taylor JM .


Abstract
Although RhoA activity is necessary for promoting myogenic mesenchymal stem cell fates, recent studies in cultured cells suggest that down-regulation of RhoA activity in specified myoblasts is required for subsequent differentiation and myotube formation. However, whether this phenomenon occurs in vivo and which Rho modifiers control these later events remain unclear. We found that expression of the Rho-GTPase-activating protein, GRAF1, was transiently up-regulated during myogenesis, and studies in C2C12 cells revealed that GRAF1 is necessary and sufficient for mediating RhoA down-regulation and inducing muscle differentiation. Moreover, forced expression of GRAF1 in pre-differentiated myoblasts drives robust muscle fusion by a process that requires GTPase-activating protein-dependent actin remodeling and BAR-dependent membrane binding or sculpting. Moreover, morpholino-based knockdown studies in Xenopus laevis determined that GRAF1 expression is critical for muscle development. GRAF1-depleted embryos exhibited elevated RhoA activity and defective myofibrillogenesis that resulted in progressive muscle degeneration, defective motility, and embryonic lethality. Our results are the first to identify a GTPase-activating protein that regulates muscle maturation and to highlight the functional importance of BAR domains in myotube formation.

PubMed ID: 21622574
PMC ID: PMC3138304
Article link: J Biol Chem.
Grant support: DE-018825 NIDCR NIH HHS, HL-070953 NHLBI NIH HHS , HL-070953 NHLBI NIH HHS , HL-070953 NHLBI NIH HHS , HL-070953 NHLBI NIH HHS , HL-070953 NHLBI NIH HHS , HL-070953 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-071054 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-081844 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , HL-089641 NHLBI NIH HHS , T32 HD046369-05 NICHD NIH HHS , T32HL69768 NHLBI NIH HHS , T32HL69768 NHLBI NIH HHS , T32HL69768 NHLBI NIH HHS , T32HL69768 NHLBI NIH HHS , T32HL69768 NHLBI NIH HHS , T32HL69768 NHLBI NIH HHS

Genes referenced: arhgap26 rho rhoa
Antibodies referenced: Somite Ab1
Morpholinos referenced: arhgap26 MO1 arhgap26 MO2

My Xenbase: [ Log-in / Register ]
version: [3.3]


Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556